On January 4, 2016, Fredric N. Eshelman has given an investor presentation to shareholders of Puma Biotechnology, Inc. in connection with its consent solicitation. In addition, Fredric N. Eshelman wrote a letter to shareholders of the Company asking their support in adding 4 additional members to the current 5 member Board of the Company.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
2.99 USD | +0.34% |
|
-3.86% | -30.95% |
![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-30.95% | 144M | |
+34.14% | 51.12B | |
-6.54% | 39.4B | |
+35.26% | 38.48B | |
+12.62% | 26.36B | |
-12.11% | 26.22B | |
-13.43% | 20.96B | |
+43.73% | 14.02B | |
+31.81% | 12.49B | |
-4.54% | 11.61B |
- Stock Market
- Equities
- PBYI Stock
- News Puma Biotechnology, Inc.
- Fredric N. Eshelman Gives Presentation to Shareholders of Puma Biotechnology